2269.HK vs 5HW: Side-by-Side Comparison
Compare WuXi Biologics (Cayman) Inc. (2269.HK) and ELEGANCE OPT.INT.HO.HD-10 (5HW) side by side: market cap HKD 142.15B vs EUR 872.86K. Financials, growth and model signals on Bullrun.
| Metric | 2269.HK | 5HW |
|---|---|---|
| Company | WuXi Biologics (Cayman) Inc. | ELEGANCE OPT.INT.HO.HD-10 |
| Country / Exchange | Hong Kong | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Instruments & Supplies |
| Market cap | HKD 142.15B | EUR 872.86K |
| P/E ratio | 25.8 | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | HKD 21.79B | EUR 14.46M |
| Revenue growth YoY | +16.7% | -39.7% |
| Net income | HKD 4.91B | EUR -20.21M |
| Gross margin | 46.0% | 7.2% |
| Diluted EPS | 1.16 | -0.02 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.